ECSP034682A - Antagonistas de receptores de aminoacidos excitatorios - Google Patents
Antagonistas de receptores de aminoacidos excitatoriosInfo
- Publication number
- ECSP034682A ECSP034682A EC2003004682A ECSP034682A ECSP034682A EC SP034682 A ECSP034682 A EC SP034682A EC 2003004682 A EC2003004682 A EC 2003004682A EC SP034682 A ECSP034682 A EC SP034682A EC SP034682 A ECSP034682 A EC SP034682A
- Authority
- EC
- Ecuador
- Prior art keywords
- ancigonists
- receivers
- amino acids
- excitatory amino
- salt
- Prior art date
Links
- 239000003257 excitatory amino acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 4
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 abstract 2
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034682A true ECSP034682A (es) | 2003-08-29 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004682A ECSP034682A (es) | 2001-01-05 | 2003-07-03 | Antagonistas de receptores de aminoacidos excitatorios |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (enExample) |
| JP (1) | JP2004520335A (enExample) |
| KR (1) | KR20030066797A (enExample) |
| CN (1) | CN1484642A (enExample) |
| AR (1) | AR035679A1 (enExample) |
| BR (1) | BR0116672A (enExample) |
| CA (1) | CA2431545A1 (enExample) |
| CZ (1) | CZ20031856A3 (enExample) |
| DZ (1) | DZ3460A1 (enExample) |
| EA (1) | EA200300770A1 (enExample) |
| EC (1) | ECSP034682A (enExample) |
| HR (1) | HRP20030544A2 (enExample) |
| HU (1) | HUP0302528A2 (enExample) |
| IL (1) | IL156138A0 (enExample) |
| MX (1) | MXPA03005981A (enExample) |
| NO (1) | NO20032973D0 (enExample) |
| NZ (1) | NZ525821A (enExample) |
| PE (1) | PE20020792A1 (enExample) |
| PL (1) | PL361934A1 (enExample) |
| SK (1) | SK8242003A3 (enExample) |
| TW (1) | TW591023B (enExample) |
| WO (1) | WO2002053561A1 (enExample) |
| ZA (1) | ZA200304311B (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| EP1053234A1 (en) * | 1998-02-06 | 2000-11-22 | Smithkline Beecham Plc | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| DZ3209A1 (fr) * | 1999-07-06 | 2001-01-11 | Lilly Co Eli | Antagonistes selectifs du recepteur iGLuR5 utilises dans le traitement de la migraine. |
-
2001
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Withdrawn
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Ceased
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
-
2002
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973D0/no not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL361934A1 (en) | 2004-10-18 |
| MXPA03005981A (es) | 2003-09-10 |
| WO2002053561A1 (en) | 2002-07-11 |
| BR0116672A (pt) | 2003-09-23 |
| CA2431545A1 (en) | 2002-07-11 |
| KR20030066797A (ko) | 2003-08-09 |
| PE20020792A1 (es) | 2002-09-06 |
| DZ3460A1 (fr) | 2002-07-11 |
| TW591023B (en) | 2004-06-11 |
| EA200300770A1 (ru) | 2003-10-30 |
| NO20032973L (no) | 2003-06-27 |
| HRP20030544A2 (en) | 2004-08-31 |
| ZA200304311B (en) | 2004-09-02 |
| CZ20031856A3 (cs) | 2003-09-17 |
| HUP0302528A2 (hu) | 2003-11-28 |
| SK8242003A3 (en) | 2004-01-08 |
| NZ525821A (en) | 2004-07-30 |
| NO20032973D0 (no) | 2003-06-27 |
| IL156138A0 (en) | 2003-12-23 |
| AR035679A1 (es) | 2004-06-23 |
| EP1351955A1 (en) | 2003-10-15 |
| JP2004520335A (ja) | 2004-07-08 |
| CN1484642A (zh) | 2004-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5271657A1 (es) | Derivados de azaindol | |
| EP1602370A3 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
| HRP20020428B1 (en) | Bicyclic amino acids as pharmaceutical agents | |
| CO5580776A2 (es) | Formulacion farmaceutica estable en solucion de oxaliplatino | |
| EA200300065A1 (ru) | Окисленные сложные эфиры 4-йодфениламинобензгидроксамовых кислот | |
| BR9900443A (pt) | Esteres de ácido aril acrìlico. | |
| BR0107837A (pt) | Processo para solubilização de compostos peptìdeo 1 semelhantes a glucagon | |
| PT1352046E (pt) | Composi??es de branqueadores ?pticos, sua produ??o e sua utiliza??o | |
| DE69507614D1 (de) | 3-amino-2-oxo-piperidinessigsäurederivate, die eine argininnachahmende verbindung, mit enzyminhibitorischen wirkung enthalten | |
| EP1392293A4 (en) | METHOD FOR THE TREATMENT OF TUMORS WITH NORDIHYDROGUAIARETINIC ACID DERIVATIVES | |
| TW200632554A (en) | Photoresist composition for deep UV and process thereof | |
| CY1120408T1 (el) | Βελτιωμενες φαρμακοτεχνικες μορφες | |
| UY27548A1 (es) | Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas | |
| BR0002073A (pt) | Processo para a preparação de um composto quiral | |
| AU4249700A (en) | Hydroxamic acid derivative | |
| BR9913670B1 (pt) | processo para a preparação de um sal de um composto de ácido carboxìlico alifático. | |
| CO5720995A2 (es) | Compuesto novedoso | |
| IT1319234B1 (it) | Processo di preparazione di gabapentina. | |
| AR021232A1 (es) | Procedimiento de preparacion de metionina. | |
| DE69327890D1 (de) | Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen | |
| EP1306367A4 (en) | SULPHONIC ACID DERIVATIVES OF HYDROXAMIC ACIDS AND THEIR USE IN MEDICAL PRODUCTS | |
| WO2002026732A1 (en) | Benzodiazepine derivative | |
| SE9902364D0 (sv) | New process | |
| AR032043A1 (es) | Un pano antimicrobiano | |
| BR0110549A (pt) | Processo para a preparação de sais de metais alcalino-terrosos do ácido d-pantotênico |